Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Mood Disorder Information Center
Case Study: Ethics and Mental Illness in Pregnancy
A woman is evaluated by psychiatry on postpartum day 2 after staff noticed her talking to the mirror in her room and not showing affection to her newborn child. Case shows ethical decisions made when managing mental illness during pregnancy.
Rykindo Approved for Schizophrenia, Bipolar Disorder
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Is Indefinite Involuntary Commitment of Unhoused Mentally Ill the Solution?
“We don’t need more police incarceration; we need a brand new mental health system with the accompanying resources required to make it work once and for all,” notes Jim Anderson, MSPAS, PA-C.
Top December 2022 FDA Approvals
December FDA approvals include treatments for weight loss in adolescents, major depressive disorder, lung cancer detection, metastatic non-small cell lung cancer, multiple sclerosis, and lymphoma.
Anxiety and Depression Association in Patients With Pediatric Psoriasis
Investigators sought to elucidate the prevalence of anxiety and depression in patients with pediatric psoriasis and advocate for psychological screening and intervention as needed.
Factors Linked to Pediatric Mental Health Emergency Revisits Identified
Psychiatric comorbidities, chemical restraint use, public insurance tied to emergency revisits; substance use disorders associated with lower likelihood of revisits.
Smartphone App May Be Beneficial for Some With Bipolar Disorder
Does not reduce risk of relapse overall, but can reduce relapse risk and manic symptom severity for low-risk individuals.
Clinician’s Duty of Care Not Negated by Patient Suicide, Court Holds
Is a clinician liable for not properly treating a patient who later dies by suicide and kills his family?
Esketamine Nasal Spray Bests Quetiapine XR in Difficult-to-Treat Depression
The trial compared Spravato (esketamine nasal spray) in the treatment of depression to quetiapine extended-release, both in combination with a continuing SSRI or SNRI.
Jessica Peck, DNP, on How to Talk to Teens About Mental Health
Dr Jessica Peck provides practical tips for clinicians and parents on how to communicate with teenagers about mental health in Behind Closed Doors.
Pediatric Migraine Tied to Anxiety, Depression Symptoms
Authors say routine screening for depression and anxiety may be beneficial in clinical practice.
Caregiver Depression Linked to Child Asthma Outcomes
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity.
Smartphone Addiction: Tips for Assessment and Management
Determining when smartphone use has become an addiction in patients is tricky. Researchers outline what to look for.
Antidepressant Use in Pregnancy Underused: Provider and Patient Perspectives
Authors describe the perspectives of patients and prescribing clinicians regarding the use of antidepressants during pregnancy.
Long-Term Psychological Effects of COVID-19
In this Director’s Memo, Nikki Kean discusses the long-term cognitive and mental health components of long COVID.
Ketamine and Psilocybin Update in Treatment-Resistant Depression
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
Anhedonia Linked to Negative, Positive Symptoms in Schizophrenia
Three clusters detected corresponding to positive symptoms, negative symptoms and work functioning, and functional domains.
Top August 2022 FDA Approvals
August 2022 FDA approvals include treatments for chronic idiopathic constipation, major depressive disorder, and testosterone replacement therapy.
Suicide Awareness During the COVID-19 Pandemic
A 22-year-old man presents to the outpatient office following an overdose of antihistamines and alcohol. He was feeling overwhelmed trying to transition to in-person classes at the university after taking online classes during the COVID-19 lockdown.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Mood Disorder Information Center
Loading... 
Loading...